1.
Yehudai-Ofir D, Khatib H, Beyar-Katz O, Frisch A, Krayem B, Zuckerman T, Henig I. Favorable safety and efficacy profiles of α-1-antitrypsin in steroid- and ruxolitinib-refractory acute graft-versus-host disease of the gastrointestinal tract: a retrospective, single center study. haematol [Internet]. 2020Sep.10 [cited 2026Apr.24];. Available from: https://haematologica.org/article/view/14147